Home > Financial Ratios > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for SUN PHARMA ADVANCED RESEARCH COMPANY
Please provide your vote to see the results

SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
   Core EBITDA Growth(%) 600.9313.76-83.40-

What is the latest Core EBITDA Growth ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?

The latest Core EBITDA Growth ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is 600.93 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026600.93
Mar202513.76
Mar2024-83.40
Mar2023-

How is Core EBITDA Growth of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?

Years Core EBITDA Growth % Change
Mar2026 600.93
4,267.22
Mar2025 13.76
Positive
Mar2024 -83.4
0
Mar2023 0 -

Other Financial Ratios of SUN PHARMA ADVANCED RESEARCH COMPANY


Compare Core EBITDA Growth ratio of peers of SUN PHARMA ADVANCED RESEARCH COMPANY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY ₹6,272.6 Cr -1.9% 0.2% 28.3% Stock Analytics
PRIME FOCUS ₹26,065.6 Cr 7% 17.5% 69.8% Stock Analytics
SAGILITY ₹20,967.7 Cr 0.5% 6.3% 0.4% Stock Analytics
SYNGENE INTERNATIONAL ₹15,337.4 Cr -1.1% -5.9% -42.5% Stock Analytics
INDEGENE ₹14,246.0 Cr 2.5% 4.3% 0.8% Stock Analytics
INTERNATIONAL GEMOLOGICAL INSTITUTE ₹13,628.2 Cr 1.1% -9.6% -13.7% Stock Analytics


SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY

-1.9%

0.2%

28.3%

SENSEX

-0.6%

-4.4%

-8.7%


You may also like the below Video Courses